What is the likelihood that a few scattered ground‑glass nodules up to 7 mm in the left upper lobe, stable for one year, are malignant in a patient with a seven‑year smoking history?

Likelihood of Malignancy in Stable Ground-Glass Nodules

The likelihood of malignancy in your scattered ground-glass nodules measuring up to 7mm that have been stable for 1 year is very low, likely less than 3%, and these nodules can be safely managed with continued surveillance rather than immediate intervention.

Risk Assessment Based on Current Evidence

The Fleischner Society 2017 guidelines 1111 provide the framework for managing your situation. For pure ground-glass nodules ≥6mm, the recommended approach is initial follow-up at 6-12 months to confirm persistence, then continued surveillance every 2 years until 5 years. Your nodules have already demonstrated 1 year of stability, which is reassuring.

Key Prognostic Factors

Stability is the most important predictor:

• Ground-glass nodules that remain stable for 1 year have a substantially lower malignancy risk
• Even when ground-glass nodules prove malignant, they typically represent indolent lesions (adenocarcinoma in situ or minimally invasive adenocarcinoma) rather than invasive cancer 11
• A large screening study found that among 2,392 pure ground-glass nodules, only 73 (3%) proved to be adenocarcinomas, with median time to treatment of 19 months and 100% overall survival for stage 1 lesions 11

Your specific risk factors:

• Size (7mm): Below the 10mm threshold that increases malignancy risk 11
• Multiple nodules: When multiple small ground-glass nodules <6mm are present, they are "usually benign" 1
• Smoking history (7 years): Moderate risk factor, though ground-glass nodules are less strongly associated with smoking than solid nodules
• 1-year stability: Strong indicator of benign behavior

Evidence-Based Management Algorithm

Continue surveillance imaging:

1. Next CT scan at 2 years from initial detection (1 year from now)
2. Subsequent CT at 4 years from initial detection
3. Final CT at 5 years from initial detection
4. If stable throughout, no further routine follow-up needed 11

Indicators that would warrant earlier intervention:

• Development of solid component within any nodule
• Increase in size or opacity
• Development of suspicious features (bubbly lucencies, irregular margins)
• New symptoms

Important Caveats

Do not assume all ground-glass nodules are malignant: Many resolve spontaneously, representing focal infection or inflammation 11. However, the 1-year stability makes spontaneous resolution less likely at this point.

The "scattered" nature matters: Multiple small ground-glass nodules <6mm are typically benign 1. If your nodules are predominantly smaller than 6mm with only one or two reaching 7mm, this further reduces concern.

Pitfall to avoid: Research shows that Lung-RADS category 2 subsolid nodules (which includes yours) actually have a 3% malignancy rate rather than the 1% originally estimated 2, but this still represents low absolute risk, and the excellent prognosis of early-stage adenocarcinoma (100% survival when detected) 11 supports continued surveillance over immediate biopsy or resection.

Patient anxiety consideration: If you are uncomfortable waiting, earlier follow-up imaging at 6 months is reasonable and may provide reassurance if nodules remain stable or resolve 11. However, this does not change outcomes given the indolent nature of these lesions.

Bottom Line

Your nodules have characteristics strongly favoring benign or very indolent disease: small size (≤7mm), pure ground-glass appearance, multiple scattered distribution, and 1-year stability. Continue annual surveillance for the next 4 years as recommended by Fleischner guidelines 11. Even in the unlikely event these represent early adenocarcinoma, the 5-year surveillance approach has been validated with excellent outcomes and 100% survival rates 11.